This programme funds preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s. We do not fund research which is directed at symptomatic relief.
For preclinical research, we fund grants up to £250,000 (GBP) and prioritise projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years. For clinical research, we fund clinical trials and sub-studies of trials in people with Parkinson’s. The grant amount is flexible but please contact us ahead of submission if you are thinking of applying for a clinical trial.
We fund internationally and accept applications from academics and commercial entities. However, the costs in commercial applications should be justified and equivalent to academic costs where possible.
Location: UK
Value: £250,000
Grant Deadline: 12-01-2026